Idorsia Ltd at JPMorgan Healthcare Conference Transcript
Good morning. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the Idorsia presentation that we're going to hear from Idorsia's CEO, Jean-Paul Clozel. Thanks very much for joining us today, and I look forward to the presentation. Thank you.
Thank you. So the sound is okay? Good. Okay.
So I just would like to explain the situation of Idorsia today because I have been in the business for quite a long time. But this is a situation where, on one side, we have fantastic products, very innovative, on the market or close to be on the market. And on the other side, we have limited financing. And what I'm trying to explain to you is how we are going to do in order to solve this issue.
So what we really want is to create a sustainable company, which means a company with a marketing organization, with a research
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |